In 2023, FDA approves far fewer first generic drugs than in recent years
Is the fall from the patent cliff finally over?
The FDA has significantly raised the bar when it comes to approving more and more generic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
